Merial’s acquisition of animal health division of Dosch Pharmaceuticals closes in India

Merial, the animal health division of Sanofi, announced the approval and closing of Merial’s acquisition of the animal health division of Dosch Pharmaceuticals, creating for Merial a market entry in India’s growing animal health market.

The signing of a binding agreement leading up to the acquisition was announced in December 2012. Merial and Dosch have now completed all regulatory approvals required for the closing of the acquisition.

The acquired business, now the animal health division of Sanofi Synthelabo India, will commence marketing Dosch’s 86 animal health products and 50 brands for ruminants, poultry and companion animals, as well as continue the process of registering Merial brands for companion and production animals for commercialisation in India.

Dr Sharat Tugnait, Chief Executive Officer, Animal Health Division, Dosch and his management team will continue to oversee the combined Merial/Dosch operations in Mumbai, India, under the executive direction of Merial India country manager, Mayank Parekh.

EP News Bureau – Mumbai